These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6131675)

  • 1. Tyrosine hydroxylase and dopamine beta-hydroxylase inhibiting properties of a new series of pyridazinyl hydrazones.
    Huszti Z; Szilágyi G; Kasztreiner E
    Biochem Pharmacol; 1983 Feb; 32(4):627-36. PubMed ID: 6131675
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential inhibitors of tyrosine hydroxylase and dopamine-beta-hydroxylase.
    Scott KR; Alt CJ; Kemp M; Hayes E; Telang VG
    J Pharm Sci; 1984 Nov; 73(11):1531-5. PubMed ID: 6151595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH; Davis WM
    J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation between serum dopamine-beta-hydroxylase activity and dopamine-beta-hydroxylase and tyrosine hydroxylase activities in central and peripheral adrenergic neurons and adrenal glands.
    Nagatsu T; Kato T; Numata Y; Ikuta K; Sano M; Nagatsu I; Takeuchi T; Matsuzaki M; Umezawa H
    Experientia; 1977 May; 33(5):581-3. PubMed ID: 16769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oudenone on adrenal tyrosine hydroxylase activity in vivo and on tissue catecholamine concentrations.
    Nagatsu T; Nagatsu I; Umezawa H; Takeuchi T
    Biochem Pharmacol; 1971 Sep; 20(9):2505-7. PubMed ID: 4147779
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of disulfiram and sodium diethyldithiocarbamate on tyrosine and dopamine-beta-hydroxylases activities in rat brain and heart.
    Szmigielski A
    Pol J Pharmacol Pharm; 1975; 27(2):153-9. PubMed ID: 239395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of dopamine -hydroxylase by 5-phenoxymethyl-2-oxazolidinethiones.
    Johnson GA; Kim EG; Boukma SJ; Lednicer D; Youngdale GA
    J Med Chem; 1972 Mar; 15(3):327-9. PubMed ID: 5059221
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
    Ahlenius S
    Brain Res; 1974 Mar; 69(1):57-65. PubMed ID: 4150408
    [No Abstract]   [Full Text] [Related]  

  • 9. Release of ( 3 H)noradrenaline and ( 3 H)dopamine from field stimulated cerebral cortex slices. Effect of tyrosine hydroxylase and dopamine- -hydroxylase inhibition.
    Farnebo LO; Hamberger B; Jonsson G
    J Neurochem; 1971 Dec; 18(12):2491-500. PubMed ID: 4400156
    [No Abstract]   [Full Text] [Related]  

  • 10. Increase of tyrosine hydroxylase activity after reserpine: evidence for the selective response of noradrenergic neurons.
    Sorimachi M
    Brain Res; 1975 Dec; 99(2):400-4. PubMed ID: 241464
    [No Abstract]   [Full Text] [Related]  

  • 11. [Derivatives of dithiocarbamic acid as inhibitors of catecholamine biosynthesis (review of the literature)].
    Korablev MV; Kurbat NM
    Farmakol Toksikol; 1977; 40(2):230-8. PubMed ID: 15863
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors.
    Andén NE; Corrodi H; Fuxe K
    J Pharm Pharmacol; 1972 Mar; 24(3):177-82. PubMed ID: 4402775
    [No Abstract]   [Full Text] [Related]  

  • 13. The occurrence and functional significance of dopamine in some peripheral adrenergic nerves of the rat.
    Snider SR; Almgren O; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(1):1-12. PubMed ID: 4145469
    [No Abstract]   [Full Text] [Related]  

  • 14. Regional disappearance of catecholamines formed from 14 C-tyrosine in rat brain: effect of synthesis inhibitors and of chlorpromazine.
    Nybäck H
    Acta Pharmacol Toxicol (Copenh); 1971; 30(5):372-84. PubMed ID: 4401187
    [No Abstract]   [Full Text] [Related]  

  • 15. The inhibitory effect of serum from diethyldithiocarbamate treated rats on bovine adrenal dopamine-beta-hydroxylase activity.
    Jarvis JA; Magos L; Jacobs R
    J Appl Toxicol; 1981 Feb; 1(1):26-9. PubMed ID: 6309944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tyrosine hydroxylase inhibition on the action of 6-hydroxydopamine.
    Jonsson G; Sachs C
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):287-96. PubMed ID: 4144667
    [No Abstract]   [Full Text] [Related]  

  • 17. Aromatic amino acid hydroxylase inhibitors. 4. 3-Substituted alpha-methyltyrosines.
    el-Masry AH; el-Masry EE; Hare LE; Counsell RE
    J Med Chem; 1975 Jan; 18(1):16-20. PubMed ID: 234013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avoidance conditioning in different strains of rats: neurochemical correlates.
    Coyle JT; Wender P; Lipsky A
    Psychopharmacologia; 1973 Jul; 31(1):25-34. PubMed ID: 4146488
    [No Abstract]   [Full Text] [Related]  

  • 19. The Role of the Brain in the Regulation of Peripheral Organs-Noradrenaline Sources in Neonatal Rats: Noradrenaline Synthesis Enzyme Activity.
    Murtazina AR; Nikishina YO; Ugrumov MV
    Dokl Biochem Biophys; 2020 Jul; 493(1):201-204. PubMed ID: 32894465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of catecholamine synthesis during ontogenic development.
    Kellogg C; Lundborg P
    Brain Res; 1973 Oct; 61():321-9. PubMed ID: 4149305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.